High sensitivity Troponin-I levels in asymptomatic hemodialysis patients

References

• Labugger R, Organ L, Collier C, et al. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 2000;102:1221–1226.
   PubMed Web of Science ®Google Scholar
• Leszyk J, Dumaswala R, Potter JD, et al. Amino acid sequence of bovine cardiac troponin I. Biochemistry. 1988;27:2821–2827.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012;125:577–583.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–2567.
   PubMed Web of Science ®Google Scholar
• Cheung AK, Sarnak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004;65:2380–2389.
   PubMed Web of Science ®Google Scholar
• Donnino MW, Karriem NV, Rivers EP, et al. Prevalence of elevated troponin I in end-stage renal disease patients receiving hemodialysis. Acad Emerg Med. 2004;11:979–981.
   PubMed Web of Science ®Google Scholar
• Hussein MM, Mooij JM, Al Malki N, et al. Troponin-I is not falsely elevated in asymptomatic dialysis patients. Saudi J Kidney Dis Transpl. 2013;24:48–53.
   PubMedGoogle Scholar
• Needham DM, Shufelt KA, Tomlinson G, et al. Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol. 2004;20:1212–1218.
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945.
   PubMed Web of Science ®Google Scholar
• Alam A, Palumbo A, Mucsi I, et al. Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patients. BMC Nephrol. 2013;14:247.
   PubMed Web of Science ®Google Scholar
• Krintus M, Kozinski M, Boudry P, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med. 2014;52:1657–1665.
   PubMed Web of Science ®Google Scholar
• Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–1581.
   PubMed Web of Science ®Google Scholar
• Kumar N, Michelis MF, DeVita MV, et al. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant. 2011;26:665–670.
   PubMed Web of Science ®Google Scholar
• Gaiki MR, DeVita MV, Michelis MF, et al. Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay. Int Urol Nephrol. 2012;44:1841–1845.
   PubMed Web of Science ®Google Scholar
• Artunc F, Mueller C, Breidthardt T, et al. Sensitive troponins–which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One. 2012;7:e47610.
   PubMed Web of Science ®Google Scholar
• Assa S, Gansevoort RT, Westerhuis R, et al. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clin Res Cardiol. 2013;102:439–445.
   PubMed Web of Science ®Google Scholar
• Cardinaels EP, Cornelis T, van der Sande FM, et al. Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins. Clin Chem Lab Med. 2015;53:e289–e292.
   PubMed Web of Science ®Google Scholar
• Skadberg O, Sandberg S, Roraas T, et al. The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. Scand J Clin Lab Invest. 2016;76:645–652.
   PubMed Web of Science ®Google Scholar
• Yildiz G, Kayatas M, Candan F, et al. What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study. Cardiorenal Med. 2013;3:136–153.
   PubMed Web of Science ®Google Scholar
• Ingec M, Oguz EG, Yildirim T, et al. The effect of hemodialysis on cardiac enzyme levels and echocardiographic parameters. Int J Artif Organs. 2014;37:513–520.
   PubMed Web of Science ®Google Scholar
• Fulop T, Tapolyai M, Qureshi NA, et al. The safety and efficacy of bedside removal of tunneled hemodialysis catheters by nephrology trainees. Ren Fail. 2013;35:1264–1268.
   PubMed Web of Science ®Google Scholar
• Antunovic T, Stefanovic A, Gligorovic Barhanovic N, et al. Prooxidant-antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up. Ren Fail. 2017;39:491–499.
   PubMed Web of Science ®Google Scholar
• Gaze DC, Collinson PO. Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis. Open Heart. 2014;1:e000108.
   PubMedGoogle Scholar
• McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008;3:19–26.
   PubMed Web of Science ®Google Scholar
• Odudu A, McIntyre CW. An Update on Intradialytic Cardiac Dysfunction. Semin Dial. 2016;29:435–441.
   PubMed Web of Science ®Google Scholar
• Sabaghian T, Hajibaratali B, Samavat S. Which echocardiographic parameter is a better marker of volume status in hemodialysis patients? Ren Fail. 2016;38:1659–1664.
   PubMed Web of Science ®Google Scholar
• Rymarz A, Gibińska J, Zajbt M, et al. Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients. Ren Fail. 2018;40:231–237.
   PubMed Web of Science ®Google Scholar
• Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584–590.
   PubMed Web of Science ®Google Scholar
• Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–2098.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
   PubMed Web of Science ®Google Scholar
• Hanafusa N, Nomura T, Hasegawa T, et al. Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients. Nephrol Dial Transplant. 2014;29:2316–2326.
   PubMed Web of Science ®Google Scholar
• Fulop T, Tapolyai MB, Zsom L, et al. Successful practice transitioning between hemodialysis and hemodiafiltration in outpatient units: ten key issues for physicians to remember. Artif Organs. 2018;42:925–932.
   PubMed Web of Science ®Google Scholar
• Grzegorzewska AE, Cieszyński K, Niepolski L, et al. Serum cardiac troponin T and effective blood flow in stable extracorporeal dialysis patients. Int Urol Nephrol. 2016;48:419–429.
   PubMed Web of Science ®Google Scholar
• Sommerer C, Heckele S, Schwenger V, et al. Cardiac biomarkers are influenced by dialysis characteristics. Clin Nephrol. 2007;68:392–400.
   PubMed Web of Science ®Google Scholar
• Goodkin DA, Young EW, Kurokawa K, et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis. 2004;44:16–21.
   PubMed Web of Science ®Google Scholar